Reply: To PMID 24504799

Affiliations

Comment

A Thiolat et al. Arthritis Rheumatol. 2014 Sep.

. 2014 Sep;66(9):2640-1.

doi: 10.1002/art.38717.

No abstract available

Comment on

Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A, Semerano L, Pers YM, Biton J, Lemeiter D, Portales P, Quentin J, Jorgensen C, Decker P, Boissier MC, Louis-Plence P, Bessis N. Thiolat A, et al. Arthritis Rheumatol. 2014 Feb;66(2):273-83. doi: 10.1002/art.38246. Arthritis Rheumatol. 2014. PMID: 24504799
Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.
Sarantopoulos A, Tselios K, Gkougkourelas I, Pantoura M, Georgiadou AM, Boura P. Sarantopoulos A, et al. Arthritis Rheumatol. 2014 Sep;66(9):2638. doi: 10.1002/art.38714. Arthritis Rheumatol. 2014. PMID: 24891239 No abstract available.
Does tocilizumab indeed reduce the frequency of Th17 cells? Comment on the article by Thiolat et al.
Samson M, Audia S, Ornetti P, Maillefert JF, Janikashvili N, Bonnotte B. Samson M, et al. Arthritis Rheumatol. 2014 Sep;66(9):2639-40. doi: 10.1002/art.38718. Arthritis Rheumatol. 2014. PMID: 24891312 No abstract available.